Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bayer
Company Monitoring Page for Bayer
latest headlines for company on cafepharma
Bayer Shakes Up Prostate Cancer Market
Motley Fool
Wed, 05/29/13 - 04:50 pm
Tags:
prostate cancer
,
Bayer
,
Xofigo
Bayer receives antitrust clearance from FTC for its acquisition of Conceptus
Yahoo/AP
Wed, 05/29/13 - 08:52 am
Tags:
FTC
,
Conceptus
,
devices
,
Bayer
,
M&A
France ignores EMA and suspends Bayer acne treatment Diane 35
CP Wire
Tue, 05/21/13 - 11:46 am
Tags:
France
,
Bayer
,
Diane 35
,
acne
Bayer, Algeta Win U.S. Approval for Prostate Cancer Drug
Bloomberg
Wed, 05/15/13 - 02:51 pm
Tags:
Bayer
,
Algeta
,
FDA
,
prostate cancer
,
Xofigo
Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/6/13 - 09:12 am
Tags:
kidney cancer
,
ONYX Pharmaceuticals
,
Bayer
,
Nexavar
,
Roche
,
Avastin
,
Inlyta
,
Sutent
,
Pfizer
,
Votrient
,
GSK
,
Afinitor
,
Novartis
,
BMS-936558
,
Bristol-Myers Squibb
,
tivozanib
,
Aveo Oncology
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Seeking Alpha
Sat, 05/4/13 - 10:32 am
Tags:
Vertex Pharmaceuticals
,
Pharmacyclics
,
Novartis
,
Celsion
,
Peregrine Pharmaceuticals
,
Prana
,
Navidea Biopharmaceuticals
,
Cardinal Health
,
ONYX Pharmaceuticals
,
Bayer
,
Sarepta
,
Hyperion Therapeutics
,
Amarin
,
Medivation
,
Astellas
,
JNJ
,
Trius
,
Sangamo BioSciences
3 Biotech Companies Ripe for a Takeover
Motley Fool
Tue, 04/30/13 - 09:00 am
Tags:
M&A
,
biotech
,
Regeneron
,
Bayer
,
Arena Pharmaceuticals
,
GSK
,
Theravance
Tackling Cancer: Thyroid Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 04/29/13 - 05:24 pm
Tags:
thyroid cancer
,
Caprelsa
,
AstraZeneca
,
Cometriq
,
Exelixis
,
Nexavar
,
Bayer
,
ONYX Pharmaceuticals
Bayer to buy birth-control devices maker for $1.1 billion
Yahoo/Reuters
Mon, 04/29/13 - 11:41 am
Tags:
Bayer
,
M&A
,
Conceptus
Bayer Earnings Rise Y/Y
Yahoo/Zacks
Sat, 04/27/13 - 09:54 am
Tags:
Bayer
Bayer Profit Barely Rises as Plastics Offset New Drugs
Bloomberg
Thu, 04/25/13 - 11:43 am
Tags:
earnings
,
Bayer
Bayer, Amgen Face Price Cuts as German Panel Expands Drug Review
Bloomberg
Thu, 04/18/13 - 10:41 am
Tags:
Germany
,
Bayer
,
Amgen
Top 10 pharma companies by employees
Fierce Pharma
Wed, 04/17/13 - 11:31 am
Tags:
Novartis
,
JNJ
,
Sanofi
,
GSK
,
Pfizer
,
Abbott Laboratories
,
Merck
,
Roche
,
Bayer
,
AstraZeneca
Bayer opposes efforts to consolidate IUD lawsuits
Reuters
Fri, 03/22/13 - 10:57 am
Tags:
IUD
,
lawsuits
,
Bayer
Bayer, J&J’s Xarelto Wins EU Backing for Expanded Use
Bloomberg
Fri, 03/22/13 - 10:46 am
Tags:
Bayer
,
JNJ
,
Europe
,
Xarelto
,
bloodthinners
Bayer Joins Merck in Fighting Generic Drugs Case
Bloomberg
Wed, 03/13/13 - 10:36 am
Tags:
Bayer
,
Merck
,
generics
Bayer eyes wider use for Xarelto with new trials
Reuters
Fri, 03/8/13 - 10:05 am
Tags:
Bayer
,
Xarelto
,
JNJ
,
percutaneous coronary intervention.
The FDA Gift That Keeps On Giving
Motley Fool
Thu, 03/7/13 - 11:31 am
Tags:
FDA
,
Bayer
,
JNJ
,
Xarelto
J&J, Bayer Fail to Win U.S. Backing for Expanded Xarelto
Bloomberg
Tue, 03/5/13 - 10:32 am
Tags:
JNJ
,
Bayer
,
Xarelto
,
FDA
,
bloodthinners
India board rules against Bayer in cancer drug patent case
Reuters
Mon, 03/4/13 - 10:43 am
Tags:
Bayer
,
India
,
patents
,
Nexavar
Pages
« first
‹ previous
…
30
31
32
33
34
35
36
37
38
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.